CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in RIGL — Rigel Pharmaceuticals Inc
CIK 884546
SAN FRANCISCO, CA
Position in RIGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,049,008
+$1,266,984 QoQ
Shares Held
154,627
-12.6% QoQ
Ownership
0.828%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. RIGL ranks #127 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in RIGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,049,008 | 154,627 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,782,024 | 176,850 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,366,079 | 148,636 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,093,960 | 179,808 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,451,406 | 77,491 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,193,402 | 66,337 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,301,985 | 77,407 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,252,445 | 77,407 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $636,301 | 77,409 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,100,550 | 743,615 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,078,241 | 743,615 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $933,341 | 864,205 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,114,824 | 864,205 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,143,535 | 866,315 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,201,045 | 800,697 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,026,120 | 869,594 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $980,105 | 867,350 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,603,372 | 870,693 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,233,767 | 842,931 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,026,958 | 833,873 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,854,534 | 427,312 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,473,722 | 430,913 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,459,965 | 417,133 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $960,746 | 400,311 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $762,731 | 416,793 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $628,842 | 403,104 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||